Although the findings are encouraging, Wellberg said much more research is needed to determine whether GLP-1 drugs could be used to prevent cancer or serve as part of cancer treatment strategies
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, whereas semaglutide activates only the GLP-1 receptor and tirzepatide targets both GIP and GLP-1 receptors
By binding to this receptor, retatrutide increases glucagon production, which stimulates the breakdown of stored forms of energy like fat and glycogen
The pharmacological action of slowing gastric emptying, whilst therapeutically beneficial for blood glucose management, frequently produces gastrointestinal side effects
Meanwhile, the deal marks something of a change in tone from Hims & Hers, which has been aggressive in its efforts to promote compounded therapies
Most people do not need a hard avoid list, but greasy fried foods, very spicy foods, high-sugar drinks, and oversized meals commonly worsen nausea or reflux